17 Jan 2022

Gennova Biopharmaceuticals Submits Phase 2 Data Of mRNA Vaccines For Covid-19

Latest reports have been coming in from Pune where Pune based pharmaceutical companies have submitted data of two vaccines for phase 2 and phase 3 COVID-19.

According to the reports coming in from Pune based Gennova Biopharmaceuticals which has submitted phase 2 data of mRNA vaccine and it has also completed the recruitment of phase 3 data. 

According to the sources Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) is also expected to review the data soon as per official sources.

Official sources has further stated that Gennova Biopharmaceuticals has also developed the mRNA vaccine for the Omicron variant that will be tested on humans for efficacy and immunogenicity soon. 

No comments:

Post a Comment